日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results

在既往对乙肝疫苗无应答的HIV感染者中应用HepB-CpG疫苗:BEe-HIVe试验的最终研究结果

Marks, Kristen M; Kang, Minhee; Umbleja, Triin; Cox, Andrea; Vigil, Karen J; Avihingsanon, Anchalee; Sugandhavesa, Patcharaphan; Katsidzira, Leolin; Kosgei, Josphat; Perazzo, Hugo; Price, Jennifer; Caruso, Stephanie; Knowles, Kevin; Alston-Smith, Beverly L; Rathod, Parita; Sherman, Kenneth E

Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 Weeks

使用多替拉韦和/或马拉维罗克强化抗逆转录病毒疗法12周后,并未影响HIV-1细胞相关的DNA、RNA和2-LTR环。

Reed, Jonathan C; Hall, Luke; McKhann, Ashley; Kwak, Ginger; Goecker, Erin A; Coombs, Robert W; Chen, Huichao; Roa, Jhoanna; Vecchio, Alyssa; Daar, Eric S; Hunt, Peter W; Marra, Christina M; Campbell, Thomas B; Ma, Qing; Swaminathan, Shobha; Macatangay, Bernard J C; Morse, Gene D; Miller, Thomas; Rusin, David; Ha, Belinda; Alston-Smith, Beverly; Paul, Robert; Letendre, Scott L; Spudich, Serena S; Greninger, Alexander L

HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial

在既往疫苗无应答的 HIV 感染者中,HepB-CpG 疫苗与 HepB-Alum 疫苗的比较:BEe-HIVe 随机临床试验

Marks, Kristen M; Kang, Minhee; Umbleja, Triin; Cox, Andrea; Vigil, Karen J; Ta, Ngan T; Omoz-Oarhe, Ayotunde; Perazzo, Hugo; Kosgei, Josphat; Hatlen, Timothy; Price, Jennifer; Katsidzira, Leolin; Supparatpinyo, Khuanchai; Knowles, Kevin; Alston-Smith, Beverly L; Rathod, Parita; Sherman, Kenneth E

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.

匹伐他汀对 HIV 患者冠状动脉疾病和炎症生物标志物的影响:REPRIEVE 随机临床试验的机制子研究

Lu Michael T, Ribaudo Heather, Foldyna Borek, Zanni Markella V, Mayrhofer Thomas, Karady Julia, Taron Jana, Fitch Kathleen V, McCallum Sara, Burdo Tricia H, Paradis Kayla, Hedgire Sandeep S, Meyersohn Nandini M, DeFilippi Christopher, Malvestutto Carlos D, Sturniolo Audra, Diggs Marissa, Siminski Sue, Bloomfield Gerald S, Alston-Smith Beverly, Desvigne-Nickens Patrice, Overton Edgar T, Currier Judith S, Aberg Judith A, Fichtenbaum Carl J, Hoffmann Udo, Douglas Pamela S, Grinspoon Steven K

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

匹伐他汀用于预防 HIV 感染者的心血管疾病

Grinspoon, Steven K; Fitch, Kathleen V; Zanni, Markella V; Fichtenbaum, Carl J; Umbleja, Triin; Aberg, Judith A; Overton, Edgar T; Malvestutto, Carlos D; Bloomfield, Gerald S; Currier, Judith S; Martinez, Esteban; Roa, Jhoanna C; Diggs, Marissa R; Fulda, Evelynne S; Paradis, Kayla; Wiviott, Stephen D; Foldyna, Borek; Looby, Sara E; Desvigne-Nickens, Patrice; Alston-Smith, Beverly; Leon-Cruz, Jorge; McCallum, Sara; Hoffmann, Udo; Lu, Michael T; Ribaudo, Heather J; Douglas, Pamela S

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

在未接种过乙肝疫苗的人类免疫缺陷病毒感染者中,含 Toll 样受体 9 激动剂佐剂的乙肝病毒疫苗的免疫原性和安全性

Marks, Kristen M; Kang, Minhee; Umbleja, Triin; Avihingsanon, Anchalee; Sugandhavesa, Patcharaphan; Cox, Andrea L; Vigil, Karen; Perazzo, Hugo; Price, Jennifer C; Katsidzira, Leolin; Vernon, Christina; Alston-Smith, Beverly; Sherman, Kenneth E

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.

人类免疫缺陷病毒神经认知障碍的抗逆转录病毒治疗强化

Letendre Scott L, Chen Huichao, McKhann Ashley, Roa Jhoanna, Vecchio Alyssa, Daar Eric S, Berzins Baiba, Hunt Peter W, Marra Christina M, Campbell Thomas B, Coombs Robert W, Ma Qing, Swaminathan Shobha, Macatangay Bernard J C, Morse Gene D, Miller Thomas, Rusin David, Greninger Alexander L, Ha Belinda, Alston-Smith Beverly, Robertson Kevin, Paul Robert, Spudich Serena

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy

在HCV/HIV合并感染中,T细胞活化与单核细胞活化相关,并在HCV直接抗病毒治疗期间下降。

Auma, Ann W N; Shive, Carey; Damjanovska, Sofi; Kowal, Corinne; Cohen, Daniel E; Bhattacharya, Debika; Alston-Smith, Beverly; Osborne, Melissa; Kalayjian, Robert; Balagopal, Ashwin; Sulkowski, Mark; Wyles, David; Anthony, Donald D

Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation

丙型肝炎病毒 (HCV) 直接抗病毒疗法适用于人类免疫缺陷病毒-HCV 基因型 1 合并感染者,可产生较高的持续病毒学应答率,且可溶性免疫激活标志物正常化程度不一

Donald D Anthony, Mark S Sulkowski, Laura M Smeaton, Sofi Damjanovska, Carey L Shive, Corinne M Kowal, Daniel E Cohen, Debika Bhattacharya, Beverly L Alston-Smith, Ashwin Balagopal, David L Wyles

Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum

REPRIEVE试验参与者的特征:跨性别群体

Smeaton, Laura M; Kileel, Emma M; Grinsztejn, Beatriz; Gardner, Edward M; Starr, Kate; Murry, Melissa L; Desvigne-Nickens, Patrice; Alston-Smith, Beverly; Waclawiw, Myron A; Cooper-Arnold, Katharine; Madruga, José V; Sangle, Shashi; Fitch, Kathleen V; Zanni, Markella V; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K; Klingman, Karin L